Category Archives: Neuroscience

Synthetic odors created by activating brain cells help neuroscientists understand how smell works – The Conversation US

When you experience something with your senses, it evokes complex patterns of activity in your brain. One important goal in neuroscience is to decipher how these neural patterns drive the sensory experience.

For example, can the smell of chocolate be represented by a single brain cell, groups of cells firing all at the same time or cells firing in some precise symphony? The answers to these questions will lead to a broader understanding of how our brains represent the external world. They also have implications for treating disorders where the brain fails in representing the external world: for example, in the loss of sight of smell.

To understand how the brain drives sensory experience, my colleagues and I focus on the sense of smell in mice. We directly control a mouses neural activity, generating synthetic smells in the olfactory part of its brain in order to learn more about how the sense of smell works.

Our latest experiments discovered that scents are represented by very specific patterns of activity in the brain. Like the notes of a melody, the cells fire in a unique sequence with particular timing to represent the sensation of smelling a unique odor.

Using mice to study smell is appealing to researchers because the relevant brain circuits have been mapped out, and modern tools allow us to directly manipulate these brain connections.

The mice we use are genetically engineered so we can activate individual brain cells simply by shining light of specific wavelengths onto them a technique known as optogenetics. Early uses of optogenetics involved light delivered through implanted optical fibers, letting researchers control coarse patches of brain cells. More recent uses of optogenetics allow more sophisticated control of precise patterns of brain activity.

For our study, we projected light patterns onto the surface of the brain, targeting a region known as the olfactory bulb. Previous research has found that when mice sniff different scents, cells in the olfactory bulb appear to fire in a sort of patterned symphony, with a unique pattern formed in response to each distinct smell.

When we shined light patterns onto a mouses olfactory bulb, it generated corresponding patterns of cellular activity. We called these patterns synthetic smells. As opposed to a pattern of activity triggered by a mouse sniffing a real odor, we directly triggered the neural activity of a synthetic smell with our light projections.

Next we trained each individual mouse to recognize a randomly generated synthetic smell. Since they cant describe to us in words what theyre perceiving, we rewarded each mouse with water if it licked a water spout whenever it detected its assigned smell. Over weeks of training, mice learned to lick when their assigned smell was activated, and not to lick for other randomly generated synthetic smells.

[Expertise in your inbox. Sign up for The Conversations newsletter and get expert takes on todays news, every day.]

We cannot say for sure that these synthetic smells correspond to any known odor in the world, nor do we know what they smell like to the mouse. But we did calibrate our synthetic patterns to broadly resemble olfactory bulb patterns observed when actual scents are present. Furthermore, mice learn to discriminate synthetic smells about as quickly as they did real smells.

Once each mouse learned to recognize its assigned synthetic smell, we measured how much they still licked when we modified the assigned smell. Within each synthetic pattern, we altered which cells were activated or when they activated.

Imagine taking a familiar song, changing individual notes in the song, and asking whether you still recognized the song after each change. By testing many different changes, one can eventually understand which precise composition of notes is essential to the songs identity and which tweaks are extreme enough to make the song unrecognizable.

Likewise, by measuring how mice changed their licking as we modified their projected light patterns, we were able to understand which combinations of cells within the pattern were important for identifying the synthetic smell.

The precise combination of cells activated was crucial. But just as important was when they are activated in an ordered sequence, akin to timed notes in a melody. For example, changing the order of cells in the sequence would render the smell unrecognizable.

It turned out that the cells activated earlier in the sequence were more important for recognition changing the sequences later in the pattern seemed to have negligible effects.

Changes in recognition were graded, and not drastic: When we changed small parts of the pattern, the smell did not become completely unrecognizable. In fact, the degree to which the smell was recognized was proportional to the degree of change in the pattern. This implies that if I slightly modify the brain activity that represents an orange, you would still smell something similar maybe recognizing it as citrus, or fruity.

So while the brain has huge capacity to store many different smells in unique timed sequences of cell activity, you can still recognize similar smells by the similarity in their patterns: The smell of coffee is still distinctly recognizable even with a splash of vanilla added to it.

The next step in this research is to bring the synthetic approach to real smells. To do so, we would need to record brain activity in response to a real smell, then reactivate the very same cells using optogenetics. The synthetic re-creation of real objects in the brain is the current focus of research in multiple labs including ours.

Addressing this issue is exciting because it opens up possibilities not just for understanding how the brain works, but also for developing brain implants that may one day restore the loss of sensory experiences.

View original post here:
Synthetic odors created by activating brain cells help neuroscientists understand how smell works - The Conversation US

How Human Brains Are Different: It Has a Lot to Do with the Connections – Scientific American

What makes the human brain special? That question is not easy to answerand will occupy neuroscientists for generations to come. But a few tentative responses can already be mustered. The organ is certainly bigger than expected for our body size. And it has its own specialized areasone of which is devoted to processing language. In recent years, brain scans have started to show that the particular way neurons connect to one another is also part of the story.

A key tool in these studies is magnetic resonance imaging (MRI)in particular, a version known as diffusion tensor imaging. This technique can visualize the long fibers that extend out from neurons and link brain regions without having to remove a piece of skull. Like wires, these connections carry electrical information between neurons. And the aggregate of all these links, also known as a connectome, can provide clues about how the brain processes information.

A persistent question about connectomes has to do with what, if anything, distinctive wiring patterns have to do with the evident cognitive differences in a mouse, a monkey or a human. A new methodology called comparative connectomics has identified some general rules of brain wiring across species that may help provide answers. In the meantime, it has also found some unique facets of the human connectome and discovered changes in the cells charged with the upkeep of brain wiring. Together these evolutionary innovations seem to keep information flowing efficiently through a large human brain. And when they are disrupted, they may give rise to psychiatric disorders.

Hypothetically, the most efficient connectome would follow a one-to-many design, with each nerve cell connecting to all of the others. But this approach is prohibitively unworkable because it requires a lot of space to house all these connections and energy to keep them functioning. Alternatively, a one-to-one design, in which each neuron connects to only a single other neuron would be less challengingbut also less efficient: information would have to traverse enormous numbers of nerve cells like stepping-stones to get from point A to point B.

Real life is in the middle, says Yaniv Assaf of Tel Aviv University, who published a survey of the connectomes of 123 mammalian species in Nature Neuroscience in June. Assaf came upon his research in a somewhat roundabout way: What began as a weekend hobby of imaging bat brains with his Tel Aviv colleague, Yossi Yovel, turned into a seven-year-long exploration of as many postmortem mammalian brains as they could borrow from a nearby veterinary institute. The investigators looked at a variety of the organsfrom the smallest bat brain, which required a magnifying glass to inspect, all the way to the human heavyweight. In between those examples were the brains of giraffes, honey badgers and cows. Among all of them, the team found the same patterns of connections at work: the number of stepping stones to get from one place to another was roughly the same in each of the organs. Differing brains used a similar wiring design.

There were some differences in how this arrangement was achieved, however. Species with few long-range connections linking the two hemispheres of their brain tended to have more short connections within each hemisphere in which nearby areas talked intensively with each other. Species with more long-range connections, such as humans and other primates, thinned out these local networks.

This approach to connectivity may reflect geometric constraints on packing a nervous system into a skull. But variations in these links within a species might also track with different abilities. If you have denser connectivity in one region, you might have a certain ability others wouldnt, Assaf says.

Though human brains follow the mammalian connection game plan, they also show some striking innovations. In a head-to-head comparison of human connectomes with those of chimpanzees, our closest living relatives, published last year, Martijn van den Heuvel of Vrije University Amsterdam and anthropologist James Rilling of Emory University revealed 33 human-specific connections. These unique links were longer and more important to network efficiency than 255 connections that were shared in the two species. The distance-spanning connections also tied together high-level associative areas in the cortex that are involved in language, tool use and imitation.

The human brain tends to have a higher investment in keeping those associative areas connected, van den Heuvel says. This setup could enable efficient integration of information from different parts of the brain, particularly those tasked with conceptual processing. I think this investment has brought us our more complicated brain functions, he adds.

When van den Heuvel and his colleagues looked at language areas, a connectivity fingerprint popped out. Chimps have their own limited versions of Brocas and Wernickes areas, the regions responsible for human language production and comprehension, respectively. But in humansthe connections between the two are stronger. And the connections from Brocas area to other regions of the brain are actually weaker. It as though the two regions have dedicated their processing might to each other and set the stage for language.

The human-specific connections may form an Achilles heel for humans, however. In a study published last November, van den Heuvel, Rilling and their colleagues found human-specific connections were more disrupted in schizophrenia. This raises the possibility that the evolution of these novel human connections came with a cost, Rilling says.

While these studies argue for the evolutionary importance of brain connections, the imaging methods are not without mistakes. They have limited resolution, so they may miss a connection ending or taking a turn. This problem means the field needs to draw from other areas of evidence to firm up the findings, says Christine Charvet, an assistant professor at Delaware State University who studies human brain evolution and was not involved in the papers.

Genomics can fill in some of the gaps. A study published in January focused on DNA segments called enhancers, which control whether genes are turned on or off. Menno Creyghton of the Erasmus University Medical Center in the Netherlands and his colleagues found that certain enhancers in humans and chimps differed significantly from those in more distantly related macaques and marmosets. This genomic remodeling took place in cells called oligodendrocytes, which wrap connections with insulating sheaths of protein. Doing so ensures electrical signals quickly reach their destination.

Creyghton suggests the cells are trying to catch up to brain expansion. These oligodendrocytes need to reinvent themselves to facilitate this larger brain, he says. So you have this one spectacular change that gives you a larger brain. And then you need lots of adaptations in the brain to cope with that.

Excerpt from:
How Human Brains Are Different: It Has a Lot to Do with the Connections - Scientific American

Research project that aims to advance neuroscience gets go ahead for 150 million final phase Research project that aims to advance neuroscience gets…

Work has started on the final stage of one of thelargest scientific projects everfunded by the European Union, with help from researchers at De Montfort University Leicester (DMU).

The Human Brain Project (HBP) has been granted150million from the European Commission to build a research infrastructureinvolvingrobots, artificial intelligence, supercomputers,bigdataanalyticsandsimulationthatcould help advanceneuroscience,brain-relatedmedicineand computing.

Experts from DMUs Centre for Computing and Social Responsibility (CCSR) have been tasked with managing the ethics-related activities andcontributing to theimplementation of responsible research and innovation across the project.

Professor Bernd Stahl, Director of the CCSR, said:DMU has a key role in the HBP, looking after the management of all ethical issues and social implications of the research.

As part of this, we provideguidanceand advice on the actual and potential impacts ofthecomputing and related technologies involved.

Establishedin 2013, the HBP isone ofthe largestresearchprojectsin Europe. Now entering the final phase of its10-year lifespan, theproject willpresent its scientific workplan and transformative technological offerings for brain research and brain-inspired research and development.

RELATED NEWSResearchers advise European Parliament on responsible AI developmentResearchers explore how artificial intelligence could impact our lives by 2025Research shows humans are attacking artificial intelligence systems

There are six elements that form the heart of the research infrastructure of the HBP, including:

The HBP also undertakestargeted research and theoreticalstudies, and exploresbrain structureand function in humans, rodents and other species.

Over the next three years, the project will narrow its focus to advance three core scientific areasthat use brain-inspired systems intended to replicate the way that humans learn, includingbrain networks, their role in consciousness, and artificial neural networks.

There are some 500 scientists involved in the project, at more than 100 universities, teaching hospitals and research centres across Europe.

For more information visit:www.humanbrainproject.eu

Posted on Monday 6th July 2020

See original here:
Research project that aims to advance neuroscience gets go ahead for 150 million final phase Research project that aims to advance neuroscience gets...

Neuroscience Market Qualitative Insights On Application 2028 3w Market News Reports – 3rd Watch News

Advances in neuroscience research pivot on relentless urge of researchers to understand relationships between neural structures, function, and behaviour. Over the past few decades, a wide slew of neuroimaging technologies have come to the fore, expanding the horizon of the neuroscience market. In conjunction with a growing body of animal models and in vitro studies, human neuroimaging studies have been key enabler for neuroscience research. Neuroscientists have leveraged wide spectrum of computational modelling, machine learning models, and data analytics to understand the aforementioned relationships, propelling new avenues in theneuroscience market.

U.S. and European Countries Research Hotspots

Interest of the governments around the world in reducing the burden of neurological diseases, including Alzheimers disease, dementia, and Parkinsons disease, has swelled substantially. Other exciting research avenues comprise headache disorders and epilepsy. Such initiatives notably include translational research and are stridently underpinning the expansion of opportunities in the neuroscience market over the decade. Particularly, the U.S. and European countries have appeared as major research hotspots. Majorly, the research is focused on identifying and testing range of cost-effective interventions, which majorly comprise population-based interventions and pharmacological interventions.

Get Sample Copy of the Report @https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6243

However, in low- and middle-income countries (LMICs), the lack of resources has led to a gap in neuroscience research to understand the epidemiology and aetiologies of neurological diseases. Further social stigma associated with psychiatric disorders are also a major roadblock in the research in neuroscience in such countries. This will create fresh streams of revenue for incumbent top shots in the neuroscience market. On the other hand, emerging economies such as China with rising per capital health expenditure have begun committing sizable funds in neuroscience research.

A large part of the research initiatives hinge around whole-brain imaging of neural circuits. The whole-brain imaging among all technologies hold a promising share in the global neuroscience market. Tellingly whole-brain imaging, neuro-microscopy and electrophysiology are likely to become staple for researchers. Neuroscientists around the world are particularly fascinated by the prospect of high-resolution projectome maps to understand the human brain.

Research in Optogenetics Gathering Steam to Unlock Novel Therapies in Neurological Disorders

The discovery of novel therapies of neurodegenerative diseases has gained drive from advances in optogeneticsmainly through the use of light-sensitive proteins. The neuroscience market has benefitted from advances being made in optical stimulation methods. These are being increasingly preferred to pharmaceutical and electrical methods and also among other brain stimulation techniques, the reason having to do with their marked accuracy and less adverse effect on tissues. The market is thus likely to draw sizable research funding in the application of these methods with the focus on understanding brain circuitries related to different psychiatric and neurological disorders, and hence finding novel treatments approaches.

Researchers have been increasingly been harnessing opsin toolbox in vivo experiments. Advent of optogenetic microelectrocorticography has opened a new frontier in this regard.

Multidisciplinary Investigations in Exercise Neuroscience Growing

New initiatives in exercise-induced brain plasticity form the fodder for non-pharmacological therapeutic and genetic research in the neuroscience market. The drive stems increasingly from the need for promoting brain fitness. Multidisciplinary investigations have further improved the understanding of brain plasticity, expanding avenues in exercise neuroscience. They are harnessing functional ultrasound imaging technologies to this end.

Moreover, advances in cellular and molecular neuroscience have broadened the horizon of neuroscience research in recent years, thereby catalyzing growth in the neuroscience market. Further, a new frontier social neuroscience is gathering traction among proponents offering technologies for behavior analysis.

Request TOC of the Report @https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6243

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Read this article:
Neuroscience Market Qualitative Insights On Application 2028 3w Market News Reports - 3rd Watch News

Team Synthesizes Safer Nonaddictive Analgesics – Technology Networks

Researchers at LSU Health New Orleans Neuroscience Center of Excellence and colleagues have discovered a new class of pipeline drugs to relieve pain and reduce fever without the danger of addiction or damage to the liver or kidneys. The research is publishedonlinein theEuropean Journal of Medicinal Chemistry.Current drugs have unwanted side effects. Opioids can not only cause addiction; recent studies have shown they can be no more effective at relieving pain than non-narcotic drugs. Non-steroidal anti-inflammatories (NSAIDs) can cause kidney damage. Acetaminophen is an effective drug, but overuse can result in liver damage.

The research team, led by Drs. Hernan A. Bazan, a professor in the Department of Surgery and Program Director of the Vascular Surgery Fellowship at Ochsner Clinic, and Surjyadipta Bhattacharjee, a post-doctoral researcher at the LSU Health New Orleans Neuroscience Center of Excellence, set out to discover what causes the liver damage associated with acetaminophen and then create a drug structurally similar to acetaminophen -- as effective, but without liver toxicity. Along with the chemistry team led by Professor Julio Alvarez-Builla, Department of Organic Chemistry at the University of Alcala in Madrid, they tested 21 different compounds as acetaminophen analogs.

Senior author Nicolas Bazan, MD, PhD, Boyd Professor and Director of LSU Health New Orleans Neuroscience Center of Excellence says, The new chemical entities reduced pain in two in models without the liver and kidney toxicity associated with current over-the-counter analgesics that are commonly used to treat pain -- acetaminophen and NSAIDs. They also reduced fever in a pyretic model. This is particularly important in the search for an antipyretic with a safer profile in the COVID-19 pandemic and its associated kidney and liver disease in critically ill SARS-CoV-2 patients.

Acute and chronic pain management is one of the most prevalent and costly public health issues worldwide. According to the Centers for Disease Control and Prevention, an estimated 50 million -- 20.4% of U.S. adults had chronic pain and 8.0% of U.S. adults had high-impact chronic pain in 2016.

Given the widespread use of acetaminophen, the risk of hepatotoxicity with overuse, and the ongoing opioid epidemic, these new chemical entities represent novel, non-narcotic analgesics that exclude hepatotoxicity, for which development may lead to safer treatment of acute and chronic pain and fever, adds Dr. Nicolas Bazan.

Other LSU Health New Orleans members of the research team included William C. Gordon, PhD, Professor of Neuroscience and Ophthalmology; Dennis Paul, PhD, Professor of Pharmacology; Scott Edwards, PhD, Associate Professor of Physiology and Neuroscience; Bokkyoo Jun, PhD, Research Instructor; and Amanda R. Pahng, PhD, a post-doctoral fellow in Dr. Edwards lab. The research team also included Drs. Carolina Burgos, Javier Recio, and Valentina Abet, at the University of Alcala in Madrid; Jessica Heap, a third-year medical student at the Tulane University School of Medicine and Alexander Ledet, a first-year MD/PhD candidate at the Albert Einstein College of Medicine in New York.

The intellectual property behind these new technologies, which are part of this discovery, have been licensed from LSU Health Sciences Center New Orleans to the life science startup South Rampart Pharma, LLC that is currently developing this new drug in late pre-clinical stages. Drs. Hernan A. Bazan, Carolina Burgos, Dennis Paul, Julio Alvarez-Builla, and Nicolas G. Bazan are named inventors on a patent assigned to LSU Health Sciences Center describing the synthesis and characterization of the novel non-hepatotoxic acetaminophen analogs (PCT/US2018/022029). The company expects to file the first FDA IND (Investigational New Drug) application by early third quarter 2020.

Our primary goal is to develop and commercialize new alternative pain medications that lack abuse potential and have fewer associated safety concerns than current treatment options, and this peer-reviewed paper describes the discovery of the initial library of compounds as well as several proof of concept animal and molecular studies, says Dr. Hernan Bazan.

The research was supported by FEDER funds, Comunidad de Madrid, Ministerio de Economia, Industria y Competitividad, Instituto de Salud Carlos III, and Universidad de Alcal.

Reference: Bazan, et al. (2020). A novel pipeline of 2-(benzenesulfonamide)-N-(4-hydroxyphenyl) acetamide analgesics that lack hepatotoxicity and retain antipyresis. European Journal of Medicinal Chemistry. DOI:https://doi.org/10.1016/j.ejmech.2020.112600

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Read the original post:
Team Synthesizes Safer Nonaddictive Analgesics - Technology Networks

Humans, Like Cats and Dogs, Perk Up Their Ears When They Hear an Interesting Sound – Technology Networks

Many animals, including dogs, cats and various species of monkeys, will move their ears to better focus their attention on a novel sound. That humans also have this capability was not known until now. A research team based in Saarland has demonstrated for the first time that we make minute, unconscious movements of our ears that are directed towards the sound want to focus our attention on. The team discovered this ability by measuring electrical signals in the muscles of the vestigial motor system in the human ear. The results have now been published in the journal eLife.Asking children to perk up their ears means asking them to listen intently. Nobody seriously thinks that kids literally move their ears the way that cats, dogs or horses do. But the fact is, they do, as researchers at the Systems Neuroscience & Neurotechnology Unit (SNNU) have now shown. The research team, led by Professor Danial Strauss, has shown that the muscles around the ear become active as soon as novel, unusual or goal-relevant sounds are perceived. The electrical activity of the ear muscles indicates the direction in which the subject is focusing their auditory attention, says neuroscientist and computer scientist Strauss. It is very likely that humans still possess a rudimentary orientation system that tries to control the movement of the pinna (the visible outer part of the ear). Despite becoming vestigial about 25 million years ago, this system still exists as a neural fossil within our brains, explains Professor Strauss. The question why pinna orienting was lost during the evolution of the primate lineage has still not been completely resolved.

The researchers were able to record the signals that control the minute, generally invisible, movements of the pinna using a technique known as surface electromyography (EMG). Sensors attached to the subjects skin detected the electrical activity of the muscles responsible for moving the pinna or altering its shape. Two types of attention were examined. To assess the reflexive attention that occurs automatically when we hear unexpected sounds, the participants in the study were exposed to novel sounds coming at random intervals from different lateral positions while they silently read a monotonous text. To test the goal-directed attention that we show when actively listening, the participants were asked to listen to a short story coming from one laterally positioned speaker, while ignoring a "competing" story from a speaker located on the opposite side. Both experiments showed that muscle movements in the vestigial pinna-orienting system indicate the direction of the subject's auditory attention.

To better characterize these minute movements of the ear, the team also made special high-definition video recordings of the subjects during the experiments. The subtle movements of the ears were made visible by applying computer-based motion magnification techniques. Depending on the type of aural stimulus used, the researchers were able to observe different upward movements of the ear as well as differences in the strength of the rearward motion of the pinnas upper-lateral edge.

Our results show that electromyography of the ear muscles offers a simple means of measuring auditory attention. The technique is not restricted to fundamental research, it also has potential for a number of interesting applications, explains Professor Strauss. One area of great practical relevance would be in developing better hearing aids. These devices would be able to amplify the sounds that the wearer is trying to hear, while suppressing the noises that they are trying to ignore. The device would function in a way that reflects the users auditory intention. The hearing aid would almost instantaneously register and interpret the electrical activity in the ear muscles. A miniature processor would gauge the direction the user is trying to direct their attention towards and then adjust the gain on the devices directional microphones accordingly.

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Continued here:
Humans, Like Cats and Dogs, Perk Up Their Ears When They Hear an Interesting Sound - Technology Networks

How Microglia Chomp Paths Through the Brain’s Scaffolding To Promote Plasticity – Technology Networks

To make new memories, our brain cells first must find one another. Small protrusions that bud out from the ends of neurons' long, branching tentacles dock neurons together so they can talk. These ports of cellular chatter -- called synapses, and found in the trillions throughout the brain -- allow us to represent new knowledge. But scientists are still learning just how these connections form in response to new experiences and information. Now, a study by scientists in UC San Francisco's Weill Institute for Neurosciences has identified a surprising new way that the brain's immune cells help out.

In recent years, scientists have discovered that the brain's dedicated immune cells, called microglia, can help get rid of unnecessary connections between neurons, perhaps by engulfing synapses and breaking them down. But the new study, published July 1, 2020 in Cell, finds microglia can also do the opposite -- making way for new synapses to form by chomping away at the dense web of proteins between cells, clearing a space so neurons can find one another. Continuing to study this new role for microglia might eventually lead to new therapeutic targets in certain memory disorders, the researchers say.

Neurons live within a gelatinous mesh of proteins and other molecules that help to maintain the three-dimensional structure of the brain. This scaffolding, collectively called the extracellular matrix (ECM), has long been an afterthought in neuroscience. For decades, researchers focused on neurons, and, more recently, the cells that support them, have largely considered the ECM unimportant.

But neurobiologists are starting to realize that the ECM, which makes up about 20 percent of the brain, actually plays a role in important processes like learning and memory. At a certain point in brain development, for example, the solidifying ECM seems to put the brakes on the rapid pace at which new neuronal connections turn over in babies, seemingly shifting the brain's priority from the breakneck adaptation to the new world around it, to a more stable maintenance of knowledge over time. Scientists also wonder if a stiffening of the extracellular matrix later in life might somehow correspond to the memory challenges that come with aging.

"The extracellular matrix has been here the whole time," said the study's first author Phi Nguyen, a biomedical sciences graduate student at UCSF. "But it's definitely been understudied."

Nguyen and his advisor, Anna Molofsky, MD, PhD, an associate professor in the UCSF Department of Psychiatry and Behavioral Sciences, first realized the ECM was important to their research on the hippocampus, a brain structure critical for learning and memory, when an experiment yielded unexpected results. Knowing that microglia chew away at obsolete synapses, they expected that disrupting microglia function would cause the number of synapses in the hippocampus to shoot up. Instead, synapse numbers dropped. And where they thought they'd find pieces of synapses being broken down in the "bellies" of microglia, instead they found pieces of the ECM.

"In this case microglia were eating something different than we expected," Molofsky said. "They're eating the space around synapses -- removing obstructions to help new synapses to form."

Before springing into action, the microglia wait for a signal from neurons, an immune molecule called IL-33, indicating that it's time for a new synapse to form, the study found. When researchers used genetic tools to block this signal, microglia failed to fulfill their ECM-chomping duties, leading to fewer new connections between neurons in the brain of mice and leaving mice struggling to remember certain details over time. When researchers instead drove the level of IL-33 signaling up, new synapses increased in number. In older mice, in which brain aging already slows the formation of new connections, ramping up IL-33 helped push the number of new synapses towards a more youthful level.

The study could be important for understanding -- and perhaps one day treating -- the kinds of memory problems we see in age related diseases like Alzheimer's, according to study co-author Mazen Kheirbek, PhD, an associate professor of psychiatry whose lab studies brain circuits involved in mood and emotion. But the findings might also be important for specific types of emotional memory problems sometimes seen in anxiety related disorders.

To determine how changes in IL-33 affect memory, the researchers taught mice to distinguish between an anxiety-inducing box (inside which the mice received a mild foot shock) and a neutral box. After a month, normal mice expressed far more fear in the shock-associated box by freezing in place (a rodent reflex to throw off predators) than they did in the neutral box, where they moved around more casually. But mice with disrupted IL-33 expressed high levels of fear in either box, suggesting they'd lost the kind of precise memory needed to determine when they should be scared and when they were safe.

Kheirbek likens this overgeneralized response to the kind of trauma-induced fear that might result from being mugged in a parking lot at night. Instead of being able to separate that fearful memory from new, perhaps less-threatening experiences, some people might develop a generalized fear that makes it hard for them to enter any parking lot at any time. "Deficits in this ability to have very precise, emotional memories are seen in a lot of anxiety disorders and particularly in PTSD," he said. "It's an overgeneralization of fear that can really interfere with your life."

For Molofsky's part, stumbling upon this unexpected finding has left her eager to learn more about the ECM and how it shapes the way we learn. Her lab is now working to identify new, poorly characterized pieces of the matrix to look for as yet undocumented ways it interacts with neurons and microglia in the brain.

"I'm in love with the extracellular matrix," Molofsky said. "A lot of people don't realize that the brain is made up not just of nerve cells, but also cells that keep the brain healthy, and even the space in between cells is packed with fascinating interactions. I think a lot of new treatments for brain disorders can come from remembering that."

Reference: Nguyen, P. T., Dorman, L. C., Pan, S., Vainchtein, I. D., Han, R. T., Nakao-Inoue, H., Taloma, S. E., Barron, J. J., Molofsky, A. B., Kheirbek, M. A., & Molofsky, A. V. (2020). Microglial Remodeling of the Extracellular Matrix Promotes Synapse Plasticity. Cell. https://doi.org/10.1016/j.cell.2020.05.050

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

View original post here:
How Microglia Chomp Paths Through the Brain's Scaffolding To Promote Plasticity - Technology Networks

Save 98% off this Master the Science of Memory, Leadership & Focus Bundle – Neowin

Today's highlighted deal comes via our Online Courses section of the Neowin Deals store, where you can save 98% off this Master the Science of Memory, Leadership & Focus Bundle. Emerge as a better, more self-aware individual! This bundle provides 16 hours of content on neuroscience, focus, memory, leadership, and more.

This buindle consists of the following courses:

For terms, certification and instructor info, click here.

This Master the Science of Memory, Leadership & Focus Bundle normally costs $1,791 but it can be yours for only $34.99, that's a saving of $1,756.01 (98%) off!

>> Get this deal, or learn more about it See all Online Courses on offer. This is a time limited deal.Get $1 credit for every $25 spent Give $10, Get $10 10% off for first-time buyers.

If this offer doesn't interest you, why not check out the following offers:

Disable Sponsored posts Other recent deals Preferred partner software

Disclosure: This is a StackCommerce deal or giveaway in partnership with Neowin; an account at StackCommerce is required to participate in any deals or giveaways. For a full description of StackCommerce's privacy guidelines, go here. Neowin benefits from shared revenue of each sale made through our branded deals site, and it all goes toward the running costs.

Read this article:
Save 98% off this Master the Science of Memory, Leadership & Focus Bundle - Neowin

AI medical research projects receive $7.1 million funding – News – The University of Sydney

Psychologists, mathematicians and data scientists at the University of Sydney are teaming up to investigate how artificial intelligence (AI) and machine learning technologies can guide effective support and treatment for people with neurological disease and mental health disorders.

The two multidisciplinary projects received more than $7 million federal funding to focus on using AI to develop technology to support youth mental health care and to build an extensive AI network for more accurate diagnosis of neurological disorders such as multiple sclerosis.

Both projects are led by the University of Sydneys Brain and Mind Centre.

The investment into Sydney-led research was announced by the Minister for Health, the Hon Greg Hunt MP as part of the Australian Governments Medical Research Future Fund (MRFF).

Our researchers are at the forefront of addressing crucial gaps in medical research that lead to better health outcomes, said Professor Duncan Ivison, Deputy Vice-Chancellor (Research).

These projects exemplify our commitment to multidisciplinary research and especially harnessing cutting edge research in artificial intelligence with outstanding neuroscience that when combined together will make an enormous contribution to the future of healthcare.

Co-Director and head of Translational Research at the Brain and Mind Centre, Professor Matthew Kiernan, said: The Brain and Mind Centre asks big questions for real-world outcomes. These research programs are based on patient-centred questions, and as such, they draw on collaborations across academic disciplines, health providers and industry partners who bring a unique depth of knowledge to each program.

Professor Michael Barnett, together with the Sydney Neuroimaging Analysis Centre (SNAC) will lead a project awarded $4.02 million to investigate how AI can be paired with medical imaging technologies to set a new standard for the diagnosis, monitoring and treatment of neurological disease.

The Translating AI Networks to Support Clinical Excellence in Neuro Diseases (TRANSCEND) project will build a new, hybrid AI learning ecosystem by training it to recognise biomarkers linked to disease progression of the common, disabling neurological condition, multiple sclerosis.

The project is a collaboration between the University of Sydney, industry specialists in medical imaging and health provider networks.

Professor Barnett, Head of Computational Neuroscience Team at the Brain and Mind Centre, said TRANSCEND fills an important research gap of the future of AI technologies to transform the health sector.

Software-generated artificial neural networks have demonstrated a remarkable capacity for (generic) image recognition. Despite the clear potential for this technology to transform health delivery, particularly through advances in medical imaging, AI research and implementation has remained the purview of research institutes and technology companies with limited access to real-world data.

By incorporating real-world data, TRANSCEND will enable new AI research and technologies within the health sector, while preserving patient privacy and data security.

Dr Frank Iorfino, research fellow in youth mental health and technology at the Brain and Mind Centre and Faculty of Medicine and Health is leading a project using AI to test and quantify the impacts of youth mental health interventions.

Leading the methods and modelling component of the project is statistician ProfessorSally Cripps, director of the University of SydneyCentre for Translational Data Scienceand theARCIndustrial Transformation TrainingCentrefor Data Analytics for Resources and Environments.

The project has been awarded more than $3.1 million.

The study will bring together data and computer scientists, who will work alongside clinicians and health services to develop digital tools that can guide clinical decisions about the appropriate interventions and treatments for young people who seek mental health care.

Mental disorders are the leading cause of disability and death among young people, said Dr Iorfino.

A key challenge for youth mental health care is how to make effective clinical decisions about the timing and sequence of interventions, particularly for those with complex needs. This three-year project will use AI to model youth mental health outcomes and quantify the impact of interventions on these outcomes.

Brain and Mind Centre Co-Director, Youth Mental Health and Policy, Professor Ian Hickie, said: From a clinical perspective, these new approaches could result in real-time decision aids that would help us to make much more accurate decisions about which early interventions are of greatest benefit to young people with emerging major mood or psychotic disorders. They will also guide our efforts to provide the most effective forms of secondary prevention.

Follow this link:
AI medical research projects receive $7.1 million funding - News - The University of Sydney

Fine-tuning brain activity reverses memory problems in mice with autism mutation – Spectrum

Social circuitry: Mice with an autism-linked mutation have better social memory after treatment that calms a related neural circuit.

Georgejason / iStock

Dampening overactive brain circuits alleviates social and spatial memory problems in a mouse model of 22q11.2 deletion syndrome, according to a new study1. The findings hint at the possibility of novel treatments for some difficulties associated with the syndrome.

Deletions of DNA in a chromosomal region known as 22q11.2 often cause intellectual disability or other cognitive difficulties, as well as psychiatric conditions such as schizophrenia. About 16 percent of people with the deletion also have autism2.

The type and severity of traits vary from person to person, in part because the deletion can span roughly 20 to 50 genes. That range makes it difficult to design targeted therapies. And many people with deletions in 22q11.2 are prone to drug-related side effects, such as seizures.

Side effects with drug treatment is one of the hardest parts of dealing with mental illness, says Julia Kahn, a postdoctoral researcher at the Childrens Hospital of Philadelphia in Pennsylvania, who worked on the study. Being able to circumvent that in a very directed manner would be really life-changing for a lot of people.

The study identifies the neural circuits responsible for select behaviors in model mice and shows that manipulating those circuits could offer a new treatment strategy.

It suggests that therapies can be symptom specific, says lead investigator Douglas Coulter, professor of pediatrics and neuroscience at the University of Pennsylvania in Philadelphia.

Coulter and his colleagues manipulated circuits in two regions of the hippocampus in 22q11.2 model mice: the ventral region, which governs social memory, and the dorsal region, involved in spatial memory. They focused on the hippocampus because it is important to social cognition in both mice and people, and previous studies have shown it is unusually small in people with 22q11.2 deletions3.

Before the manipulation, mice missing 22q11.2 perform worse than controls on tests of their social and spatial memory, the study shows. The mice do not distinguish between a new mouse and one they have already met, and they have trouble recognizing when an object in their cage has been moved. Brain imaging also showed that the model mice have overactive neurons in the hippocampus.

The team used a method known as chemogenetics to dampen this overactivity. They gave the mice an injection that prompts some neurons in the hippocampus to produce designer receptors. They then injected the animals with an experimental drug that binds only to those receptors, making the neurons less excitable.

The animals behaviors changed, depending on where they received the injection. Social memory improved when the drug targeted the ventral hippocampus, and spatial memory improved when the drug affected neurons in the dorsal area. Too much inhibition in either area caused the animals memory problems to return.

Using the same technique, the researchers also gave control mice drug-sensitive receptors that either activate or quell the same circuits in the hippocampus. After both treatments, the controls showed the same social memory problems as the mice with 22q11.2 deletions. The results indicate that disrupting the circuits in either direction is enough to change behavior, even without any underlying genetic mutations. The findings were published in May in Biological Psychiatry.

Chemogenetics is a long way off from use in people, but drugs currently on the market may be able to achieve similar outcomes by nudging circuits into a more balanced state, says Peter Scambler, professor of molecular medicine at University College London in England, who was not involved in the work.

Its a proof of principle, he says.

Manipulating circuits that govern specific behaviors should be a goal of all current work at this point, says Anthony LaMantia, professor of developmental disorders and genetics at Virginia Polytechnic Institute and State University in Blacksburg, who was not involved in the work. This is much more targeted and precise. It should make everybody in the field think through how to design their experiments.

Targeting circuits in the hippocampus could help people, because findings in the hippocampus in mice typically translate well to humans, says Rebecca Piskorowski, head of the synaptic plasticity and neuronal circuits team at the Institute of Psychiatry and Neuroscience of Paris in France, who was not involved in the work.

This kind of targeting might also help at any age. The method improved memory in adult mice, suggesting similar treatments could help older people with 22q11.2 deletions and not just children.

This paper shows if you just adjust the activity in a tiny little place, you can somehow compensate for all those developmental problems, Piskorowski says. That is particularly exciting.

Visit link:
Fine-tuning brain activity reverses memory problems in mice with autism mutation - Spectrum